PROSTAGRAM trial results published
Results of the PROSTAGRAM trial, held at Imperial College London and Paul Strickland Scanner Centre, have just been published in the prestigious medical journal, JAMA Oncology.
Medical research boosts survival rates and makes in particular cancer treatment kinder on people diagnosed in the future. See some of our research articles below:
Results of the PROSTAGRAM trial, held at Imperial College London and Paul Strickland Scanner Centre, have just been published in the prestigious medical journal, JAMA Oncology.
People being treated for metastatic breast cancer could be granted precious extra healthy time with their loved ones, thanks to the results of a landmark research study supported by Paul Strickland Scanner Centre.
The extent to which MRI scans can spare men suspected of having prostate cancer unnecessary biopsies and prevent needless treatment has been highlighted by an authoritative new research paper.
A short MRI scan is better at detecting aggressive prostate cancer than the commonly used Prostate Specific Antigen (PSA) test, according to a groundbreaking medical research trial held at Imperial College London and Paul Strickland Scanner Centre.
An evaluation of a highly specialist scan at Paul Strickland Scanner Centre that can catch prostate cancer earlier and possibly result in a cure has had a dramatic effect on patients’ management and treatment, according to a study carried out at the centre. Results of the study were presented at
New tracers in PET-CT imaging could make a real difference to cancer patients, says Dr Kathryn Wallitt, consultant radiologist at Paul Strickland Scanner Centre.
An honorary Consultant Radiologist at Paul Strickland Scanner Centre at Mount Vernon Hospital has won a prestigious award in a pan European competition, it has been announced.
What if, 5 to 10 years from now, a simple blood test could not only be used to detect cancer but even tell your doctor which treatment would work best for you? This could be the result of a research study which is being supported by Paul Strickland Scanner Centre.
Doctors are very interested in our ability to carry out dual-energy scans and have approached us for research projects as a result.
Pancreatic cancer patients could benefit from the results of a major national study in which Paul Strickland Scanner Centre played a key role, according to an NHS Health Technology Assessment that has just been published. Improved diagnosis and staging The PET-PANC study, funded by the National Institute for Health Research
What if the scan itself, combined with the right treatments, could be the key to transforming the treatment for metastatic breast cancer? When people hear about breakthroughs in cancer treatment, they often think of drugs that target the cancer almost instantly, with “before” and “after” scans showing how one or
Mount Vernon Hospital
Northwood, Middlesex
HA6 2RN
Registered charity no. 298867
Registered company no. 2033936 (England and Wales)
About us
Support us
Help